PMID- 30633749 OWN - NLM STAT- MEDLINE DCOM- 20190918 LR - 20220913 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 14 IP - 1 DP - 2019 TI - Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population. PG - e0206955 LID - 10.1371/journal.pone.0206955 [doi] LID - e0206955 AB - Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity, mainly by neutrophil elastase (HNE), in the lung parenchyma. This is the result of a substantial reduction of circulating alpha-1-antitrypsin (AAT) and the presence in the plasma of inactive polymers of AAT. Moreover, some AAT mutants have reduced intrinsic activity toward HNE, as demonstrated for the common Z mutant, as well as for other rarer variants. Here we report the identification and characterisation of the novel AAT reactive centre loop variant Gly349Arg (p.G373R) present in the ExAC database. This AAT variant is secreted at normal levels in cellular models of AATD but shows a severe reduction in anti-HNE activity. Biochemical and molecular dynamics studies suggest it exhibits unfavourable RCL presentation to cognate proteases and compromised insertion of the RCL into beta-sheet A. Identification of a fully dysfunctional AAT mutant that does not show a secretory defect underlines the importance of accurate genotyping of patients with pulmonary AATD manifestations regardless of the presence of normal levels of AAT in the circulation. This subtype of disease is reminiscent of dysfunctional phenotypes in anti-thrombin and C1-inibitor deficiencies so, accordingly, we classify this variant as the first pure functionally-deficient (type II) AATD mutant. FAU - Laffranchi, Mattia AU - Laffranchi M AUID- ORCID: 0000-0002-0556-6068 AD - Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. FAU - Elliston, Emma L K AU - Elliston ELK AD - UCL Respiratory and the Institute of Structural and Molecular Biology, University College London, London, United Kingdom. FAU - Gangemi, Fabrizio AU - Gangemi F AUID- ORCID: 0000-0001-9389-651X AD - Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. FAU - Berardelli, Romina AU - Berardelli R AD - Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. FAU - Lomas, David A AU - Lomas DA AD - UCL Respiratory and the Institute of Structural and Molecular Biology, University College London, London, United Kingdom. FAU - Irving, James A AU - Irving JA AUID- ORCID: 0000-0003-3204-6356 AD - UCL Respiratory and the Institute of Structural and Molecular Biology, University College London, London, United Kingdom. FAU - Fra, Annamaria AU - Fra A AUID- ORCID: 0000-0002-4327-3004 AD - Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. LA - eng GR - MR/N024842/1/MRC_/Medical Research Council/United Kingdom GR - WT_/Wellcome Trust/United Kingdom GR - DH_/Department of Health/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190111 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Mutant Proteins) RN - 0 (alpha 1-Antitrypsin) SB - IM MH - Amino Acid Sequence MH - *Genetic Variation MH - *Genetics, Population MH - Humans MH - Models, Biological MH - Molecular Dynamics Simulation MH - Mutant Proteins/chemistry/metabolism MH - Protein Domains MH - Protein Structure, Secondary MH - alpha 1-Antitrypsin/chemistry/*genetics/*metabolism PMC - PMC6329500 COIS- The authors have declared that no competing interests exist. EDAT- 2019/01/12 06:00 MHDA- 2019/09/19 06:00 PMCR- 2019/01/11 CRDT- 2019/01/12 06:00 PHST- 2018/10/17 00:00 [received] PHST- 2019/01/02 00:00 [accepted] PHST- 2019/01/12 06:00 [entrez] PHST- 2019/01/12 06:00 [pubmed] PHST- 2019/09/19 06:00 [medline] PHST- 2019/01/11 00:00 [pmc-release] AID - PONE-D-18-30133 [pii] AID - 10.1371/journal.pone.0206955 [doi] PST - epublish SO - PLoS One. 2019 Jan 11;14(1):e0206955. doi: 10.1371/journal.pone.0206955. eCollection 2019.